Abstract:Development of hepatitis C virus (HCV) entry inhibitors represents an emerging approach that satisfies a tandem mechanism for use with other inhibitors in a multifaceted cocktail. By screening Chinese herbal extracts, oleanolic acid (OA) was found to display weak potency to inhibit HCV entry with an IC50 of 10 mu M. Chemical exploration of this triterpene compound revealed its pharmacophore requirement for blocking HCV entry, rings A, B, and E, are conserved while ring D is tolerant of some modifications. Hydroxylation at C-16 significantly enhanced its potency for inhibiting HCV entry with IC50 at 1.4 mu M. Further modification by conjugation of this new lead with a disaccharide at 28-COOH removed the undesired hemolytic effect and, more importantly, increased its potency by similar to 5-fold (54a, IC50 0.3 mu M). Formation of a triterpene dimer via a linker bearing triazole (70) dramatically increased its potency with IC50 at similar to 10 nM. Mechanistically, such functional triterpenes interrupt the interaction between HCV envelope protein E2 and its receptor CD81 via binding to E2, thus blocking virus and host cell recognition. This study establishes the importance of triterpene natural products as new leads for the development of potential HCV entry inhibitors.

Conjugation of Cyclodextrin with Fullerene As a New Class of HCV Entry Inhibitors

Synthesis and biological evaluation of novel pentacyclic triterpene α-cyclodextrin conjugates as HCV entry inhibitors

Synthesis and Anti‐HCV Entry Activity Studies of Β‐cyclodextrin–pentacyclic Triterpene Conjugates

Design, synthesis and biological evaluation of water-soluble per-O-methylated cyclodextrin-C60 conjugates as anti-influenza virus agents.

Preparation and applications of cyclodextrins monolayer/multilayers membranes

Facile preparation and characterization of novel oleanane-type triterpene functionalized β-cyclodextrin conjugates

Synthesis of Water-Soluble 2-Alkylcyclodextrin–c60 Conjugates and Their Inclusion Complexation in Aqueous Solution

Design, Synthesis and Biological Evaluation of Pentacyclic Triterpene Dimers as HCV Entry Inhibitors

Novel Β-Cyclodextrin-based Heptavalent Glycyrrhetinic Acid Conjugates: Synthesis, Characterization, and Anti-Influenza Activity.

Broad Synthesis of Disubstituted Dihydrofuran-Fused [60]Fullerene Derivatives via Cu(I)/Ag(I)-Mediated Synergistic Annulation Reaction.

Synthesis and structure-activity relationship studies of water-soluble β-cyclodextrin-glycyrrhetinic acid conjugates as potential anti-influenza virus agents.

Preparation and Application of Membrane with Cyclodextrins

Development of Bivalent Oleanane-Type Triterpenes As Potent HCV Entry Inhibitors.

Supramolecular self-assembly and nanoencapsulation of [60]fullerene by bis-β-cyclodextrin

Deep Cavitand Calixarene–Solubilized Fullerene as a Potential Photodynamic Agent

Coarse-grain Molecular Dynamics Study of Fullerene Transport across a Cell Membrane

Synthesis and bioevaluation of water-soluble β-cyclodextrin–diterpene acid conjugates

Redox Potentials and Binding Enhancement of Fullerene and Fullerene–cyclodextrin Systems in Water and Dimethylsulfoxide

Chlorcyclizine Inhibits Viral Fusion of Hepatitis C Virus Entry by Directly Targeting HCV Envelope Glycoprotein 1

Development Of Oleanane-Type Triterpenes As A New Class Of Hcv Entry Inhibitors

Dendritic Cell Lectin-Targeting Sentinel-Like Unimolecular Glycoconjugates to Release an Anti-Hiv Drug.